Most Popular Stories
- GSK, Takeda say nay to in-house diagnostics units
- EMC to found Russian cloud computing, 'Big Data' hub
- Being more like Coca-Cola takes days out of GSK's pharma supply chain
- Merck says Victrelis can interfere with HIV meds
- Psychologists petition against DSM-5 revisions
- WellPoint to drop branded Lipitor from its formulary
Webinars
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Featured Jobs
-
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Manager Business Development
Clinical Resource Network - US West Coast -
Associate Manager, Global Supply Chain Planning (1 of 3) Job
Celgene Corporation - Basking Ridge, NJ, US
Events
- Just Released: New Trends in Preventive and Therapeutic Vaccine
- Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Pharmaceutical Strategic Outlook
April 11-13, 2012 - Euro-Biotech Partnering Summit
May 30-June 1, 2012 — Paris, France
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Biologically Active Molecules: Chemical Research, Development and Scale-up
- The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
- Tar Heel Biotech: The Policies, Trends, and Investments That Continue to Promote Growth in North Carolina's Biotechnology Sector
- API in Capsule: Common "First in Man" approaches vs. The Lost Art of Formulation Development
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
- The Cutting Edge of Chemistry
Kelly Martin, Elan CEO
Related Articles:
Shareholder tells Elan to fire CEO
Elan's Martin: Worst biotech CEO?
